Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 1;7(8):e2431110.
doi: 10.1001/jamanetworkopen.2024.31110.

Consumer Perceptions of Safety Information in Direct-to-Consumer Print Advertisements for Alzheimer Drugs

Jenny Markell  1 , Ilina Odouard  1 , Gerard F Anderson  1 , Michael J DiStefano  2
Affiliations

Consumer Perceptions of Safety Information in Direct-to-Consumer Print Advertisements for Alzheimer Drugs

Jenny Markell et al. JAMA Netw Open. .
No abstract available

Plain language summary

This survey study assesses the effectiveness of drug advertisement to shape perception of the benefits and risks of and personal willingness to use and recommend an advertised drug.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Ms Odouard reported being previously employed as a consultant at Blue Matter Consulting and Health Technology Analysts outside the submitted work. Dr DiStefano reported receiving grants from the PhRMA Foundation and the Institute for Clinical and Economic Review outside the submitted work. No other disclosures were reported.

Similar articles

See all similar articles

References

    1. US Food and Drug Administration. Presenting quantitative efficacy and risk information in direct-to-consumer (DTC) promotional labeling and advertisements. Updated December 2023. Accessed January 15, 2024. https://www.fda.gov/regulatory-information/search-fda-guidance-documents...
    1. Sullivan HW, O’Donoghue AC, Aikin KJ. Communicating benefit and risk information in direct-to-consumer print advertisements: a randomized study. Ther Innov Regul Sci. 2015;49(4):493-502. doi:10.1177/2168479015572370 - DOI - PMC - PubMed
    1. 21 CFR Sect. 202.1. Prescription drug advertisements . Accessed July 10, 2024. https://www.ecfr.gov/current/title-21/part-202/section-202.1
    1. Mahase E. Alzheimer’s disease: lecanemab gets full FDA approval and black box safety warning. BMJ. 2023;382:1580. doi:10.1136/bmj.p1580 - DOI - PubMed
    1. Garrett JB, Tayler WB, Bai G, Socal MP, Trujillo AJ, Anderson GF. Consumer responses to price disclosure in direct-to-consumer pharmaceutical advertising. JAMA Intern Med. 2019;179(3):435-437. doi:10.1001/jamainternmed.2018.5976 - DOI - PMC - PubMed